Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Caputo, Viviana ^a,b   Sinibaldi, Lorenzo ^c   Fiorentino, Alessia ^d   Parisi, Chiara ^a,b   Catalanotto, Caterina ^a,b   Pasini, Augusto ^e   Cogoni, Carlo ^a,b   Pizzuti, Antonio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; MICRORNA; MICRORNA 26A; MICRORNA 26B; UNCLASSIFIED DRUG; LUCIFERASE; MIRN26A MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; PROTEIN TRANSPORT; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BASE PAIRING; BIOLOGY; ENZYME ASSAY; GENE EXPRESSION REGULATION; GENETICS; HAPLOTYPE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; REPRODUCIBILITY; SCHIZOPHRENIA; SEQUENCE ALIGNMENT;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; BASE PAIRING; BASE SEQUENCE; BINDING SITES; BRAIN-DERIVED NEUROTROPHIC FACTOR; COMPUTATIONAL BIOLOGY; ENZYME ASSAYS; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LUCIFERASES; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SEQUENCE ALIGNMENT;

EID: 83355168037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028656     Document Type: Article

References (74)

1. Huang EJ, Reichardt LF, (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
2. Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD, (2002) From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 9 (5): 224-237.
3. Yamada K, Mizuno M, Nabeshima T, (2002) Role for brain-derived neurotrophic factor in learning and memory. Life Sci 70 (7): 735-744.
4. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2): 257-269.
5. Rybakowski JK, Borkowska A, Czerski PM, Skibińska M, Hauser J, (2003) Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5 (6): 468-472.
6. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, et al. (2003) A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28 (2): 397-401.
7. Itoh K, Hashimoto K, Kumakiri C, Shimizu E, Iyo M, (2004) Association between brain-derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects. Am J Med Genet B Neuropsychiatr Genet 124B (1): 61-63.
8. Tsai SJ, Hong CJ, Yu YW, Chen TJ, (2004) Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 49 (1): 13-16.
9. Hawi Z, Straub RE, O'Neill A, Kendler KS, Walsh D, et al. (1998) No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Res 81 (2): 111-116.
10. Wassink TH, Nelson JJ, Crowe RR, Andreasen NC, (1999) Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. Am J Med Genet 88 (6): 724-728.
11. Krebs MO, Guillin O, Bourdell MC, Schwartz JC, Olie JP, et al. (2000) Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 5 (5): 558-562.
12. Nanko S, Kunugi H, Hirasawa H, Kato N, Nabika T, et al. (2003) Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr Res 62 (3): 281-283.
13. Momose Y, Murata M, Kobayashi K, Tachikawa M, Nakabayashi Y, et al. (2002) Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 51 (1): 133-136.
14. Håkansson A, Melke J, Westberg L, Shahabi HN, Buervenich S, et al. (2003) Lack of association between the BDNF Val66Met polymorphism and Parkinson's disease in a Swedish population. Ann Neurol 53 (6): 823.
15. Hong CJ, Liu HC, Liu TY, Lin CH, Cheng CY, et al. (2003) Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset. Neurosci Lett 353 (1): 75-77.
16. Toda T, Momose Y, Murata M, Tamiya G, Yamamoto M, et al. (2003) Toward identification of susceptibility genes for sporadic Parkinson's disease. J Neurol 250 (Suppl.3): III40-III43.
17. Uhl GR, Liu QR, Walther D, Hess J, Naiman D, (2001) Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet 69 (6): 1290-1300.
18. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, et al. (2001) A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 6 (1): 83-86.
19. Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE, et al. (2004) Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 49 (1): 10-12.
20. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, et al. (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71 (3): 651-655.
21. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, et al. (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7 (6): 579-593.
22. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, et al. (2003) Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 337 (1): 17-20.
23. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ, (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 123B (1): 19-22.
24. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M, (2003) Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73 (2): 370-376.
25. Gratacòs M, González JR, Mercader JM, de Cid R, Urretavizcaya M, et al. (2007) Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61 (7): 911-922.
26. Ribasés M, Gratacòs M, Armengol L, de Cid R, Badía A, et al. (2003) Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 8 (8): 745-751.
27. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, et al. (2005) Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 139B (1): 51-53.
28. Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, et al. (2006) Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci 60 (1): 70-76.
29. Rosa A, Cuesta MJ, Fatjó-Vilas M, Peralta V, Zarzuela A, et al. (2006) The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am J Med Genet B Neuropsychiatr Genet 141B (2): 135-138.
30. Chiaruttini C, Vicario A, Li Z, Baj G, Braiuca P, et al. (2009) Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proc Natl Acad Sci USA 106 (38): 16481-16486.
31. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, et al. (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 5: 24.
32. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 (2): 102-114.
33. Brennecke J, Stark A, Russell RB, Cohen SM, (2005) Principles of microRNA-target recognition. PLoS Biol 3 (3): e85.
34. Krol J, Loedige I, Filipowicz W, (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11 (9): 597-610.
35. Kartha RV, Subramanian S, (2010) MicroRNAs in cardiovascular diseases: biology and potential clinical applications. J Cardiovasc Transl Res 3 (3): 256-270.
36. Gambardella S, Rinaldi F, Lepore SM, Viola A, Loro E, et al. (2010) Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med 8: 48.
37. Georgel P, Schuster C, Zeisel MB, Stoll-Keller F, Berg T, et al. (2010) Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. Trends Mol Med 16 (6): 277-286.
38. Kong L, Zhu J, Han W, Jiang X, Xu M, et al. (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48 (1): 61-9.
39. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, et al. (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317 (5842): 1220-1224.
40. Bhagavathi S, Czader M, (2010) MicroRNAs in benign and malignant hematopoiesis. Arch Pathol Lab Med 134 (9): 1276-1281.
41. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10 (10): 704-714.
42. Xu B, Karayiorgou M, Gogos JA, (2010) MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res 1338: 78-88.
43. Xu Y, Li F, Zhang B, Zhang K, Zhang F, et al. (2010) MicroRNAs and target site screening reveals a pre-microRNA-30e variant associatedwith schizophrenia. Schizophr Res 119 (1-3): 219-27.
44. Meza-Sosa KF, Valle-Garcìa D, Pedraza-Alva G, Pèrez-Martìnez L, (2012) Role of microRNAs in central nervous system development and pathology. J Neurosci Res 90 (1): 1-12.
45. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T, (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90 (3): 397-406.
46. Cui Q, Yu Z, Pan Y, Purisima EO, Wang E, (2007) MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Biochem Biophys Res Commun 352 (3): 733-8.
47. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115 (7): 787-798.
48. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S, (2008) A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 17 (19): 3030-3042.
49. Chandrasekar V, Dreyer JL, (2009) MicroRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 42 (4): 350-362.
50. Friedman LM, Dror AA, Mor E, Tenne T, Toren G, et al. (2009) MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. Proc Natl Acad Sci USA 106 (19): 7915-7920.
51. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, et al. (2009) An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem 284 (50): 35134-35143.
52. Chen K, Rajewsky N, (2006) Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38 (12): 1452-1456.
53. Saunders MA, Liang H, Li WH, (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104 (9): 3300-3305.
54. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, et al. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310 (5746): 317-320.
55. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, et al. (2007) Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 81 (4): 829-834.
56. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, et al. (2007) The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 282 (33): 24262-24269.
57. Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, et al. (2009) A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol Psychiatry 14 (4): 381-389.
58. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, et al. (2007) PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 35: D51-54.
59. Georges M, Coppieters W, Charlier C, (2007) Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 17 (3): 166-176.
60. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, et al. (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81 (2): 405-413.
61. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10 (6): 389-402.
62. Hayes VY, Towner MD, Isackson PJ, (1997) Organization, sequence and functional analysis of a mouse BDNF promoter. Brain Res Mol Brain Res 45 (2): 189-198.
63. Ghosh A, Carnahan J, Greenberg ME, (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263 (5153): 1618-1623.
64. Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, et al. (1993) Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10: 475-489.
65. Castrén E, Berninger B, Leingärtner A, Lindholm D, (1998) Regulation of brain-derived neurotrophic factor mRNA levels in hippocampus by neuronal activity. Prog Brain Res 117: 57-64.
66. An JJ, Gharami K, Liao GY, Woo NH, Lau AG, et al. (2008) Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134 (1): 175-187.
67. Lau AG, Irier HA, Gu J, Tian D, Ku L, et al. (2010) Distinct 3'UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc Natl Acad Sci USA 107 (36): 15945-15950.
68. Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, et al. (2005) Human brain derived neurotrophic factor (BDNF)genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B Neuropsychiatr Genet 134B (1): 93-103.
69. Smirnova L, Gräfe A, Seiler A, Schumacher S, Nitsch R, et al. (2005) Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21 (6): 1469-1477.
70. Rinaldi A, Vincenti S, De Vito F, Bozzoni I, Oliverio A, et al. (2010) Stress induces region specific alterations in microRNAs expression in mice. Behav Brain Res 208 (1): 265-269.
71. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, et al. (2007) Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2 (9): e873.
72. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, et al. (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8 (2): R27.
73. Excoffier, Laval LG, Schneider S, (2005) Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online 1: 47-50.
74. Shi YY, He L, (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15 (2): 97-98.